Investors / United States / First In Ventures
First In Ventures
Venture capital · Middletown, DE, United States · North America
First In Ventures is an early-stage biotech investment firm that provides seed capital, follow-on capital and industry experience at the intersection of genomics and data science. It partners with a life sciences accelerator to supply early-stage capital, often as first money in, along with mentoring and management advice to founders.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsbiotechlife sciencesgenomicsdata scienceseed stage
Your fit with First In Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFirst In Ventures lists 13 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (69%), AI & Machine Learning (19%) and Cybersecurity (6%). 67% of its companies are based in United States. It invests most often alongside Ascension, BankTech Ventures and Better Ventures.
Counts come from funding rounds that name First In Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not First In Ventures' whole history. Rounds on record name 1 company; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 91th | 69% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Ascension | 1 |
| BankTech Ventures | 1 |
| Better Ventures | 1 |
| BlueWing Ventures | 1 |
| Brace Pharma Capital | 1 |
| Entrepreneurs First | 1 |
| FTW Ventures | 1 |
| ID Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1292%
- No longer answers00%
- Points to another company18%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 69% | 15% |
| AI & Machine Learning | 19% | 18% |
| Cybersecurity | 6% | 4% |
| Food & Agriculture | 6% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare First In Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with First In Ventures| Date | Company | Stage |
|---|---|---|
| 24 Oct 2023 | Series B |
Round details for First In Ventures
Amounts, full round histories and every co-investor in First In Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company provides genomic testing and precision oncology solutions using AI-powered insights and global genomics data to personalize cancer care. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Adlumin provides security operations and management solutions, including XDR and MDR services, to managed service providers and IT teams. | CybersecurityAI & Machine Learning | Oct 2023Series B | Funding round | |
| BiotaX discovers and constructs natural-based microbial communities for health, food, agriculture, and climate applications | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Celldom develops a live single-cell biology platform to identify cellular morphology, phenotypes, activity, and molecular profile in real-time at high throughput. | Healthcare & Biotech | Portfolio page | ||
| Flightpath Biosciences develops a platform designed to interrupt disease before it becomes irreversible by eliminating root-cause bacteria | Healthcare & Biotech | Portfolio page | ||
| Futura Genomics offers DNA tests that provide insights into health, performance, wellbeing, and heritage | Healthcare & Biotech | Portfolio page | ||
| Gliknik discovers and develops drugs for immune disorders, including autoimmune diseases and cancers. | Healthcare & Biotech | Portfolio page | ||
| Humacyte is pioneering a platform that enables the investigation, development, and manufacture of bioengineered human tissues and organs | Healthcare & Biotech | Portfolio page | ||
| Lassogen engineers lasso peptides to create a new class of programmable medicines | Healthcare & Biotech | Portfolio page | ||
| Mitra provides a non-invasive skin epigenetic test to measure biological age and offers personalized skincare plans based on the results | Healthcare & Biotech | Portfolio page | ||
| Stem Pharm engineers human biology to redefine neurologic drug discovery | Healthcare & Biotech | Portfolio page | ||
| Tailor Bio develops targeted cancer therapies for chromosomal instability | Healthcare & Biotech | Portfolio page | ||
| Yali Bio makes climate-friendly fats for use in food products like butter and ice cream | Food & Agriculture | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- firstinventures.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 24 Oct 2023
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get First In Ventures' profile as data
Pull First In Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/firstinventures.com
# also
GET /v1/firms/firstinventures.com/portfolio
GET /v1/firms/firstinventures.com/coinvestors
GET /v1/firms/firstinventures.com/news